NWPSHP Fall CE Day

October 25, 2019

New medications, indications, and study results that pharmacists and technicians need to be aware of

Target Audience

Pharmacists

Pharmacy Technicians

Learning Objectives

Learning objectives for Pharmacists:

  1. List 3 logistical issues that pharmacy students struggle with while on clinical rotations.
  2. Recite 3 free technologies available for preceptors to place useful information for students to access.  
  3. Reflect upon the utility of using games or polling systems to improve information retention.
  4. Summarize the 2018 AHA/ACC guideline recommendations on the management of cholesterol.
  5. Review supported literature and discuss the role of PCSK9 inhibitors for secondary clinical ASCVD prevention. 
  6. Review background information about imipenem, cilastatin, and relebactam including mechanism of action, indications, and adverse effects
  7. Discuss and analyze the current available literature to determine the appropriate use of imipenem, cilastatin, and relebactam
  8. Describe the proposed mechanism of action of pitolisant
  9. Recognize the common dosing, dosing adjustments for special populations, drug interactions, and adverse effects of pitolisant
  10. Outline the major change in the 2019 Global Initiative for Asthma (GINA) guidelines
  11. Discuss budesonide-formoterol’s place in therapy for mild asthma based on recent literature
  12. Review sacubitril/valsartan and supporting literature leading to FDA approval
  13. Discuss new literature detailing the potential new indications/patient populations for the use of sacubitril/valsartan
  14. Describe the incidence of penicillin allergies
  15. Illustrate the role of the pharmacist in appropriate interventions in patients with penicillin allergies
  16. Distinguish when it is appropriate to treat for a urinary tract infection (UTI) in hospitalized patients
  17. Identify the outcomes associated with antibiotic treatment of hospitalized patients with asymptomatic bacteriuria
  18. Evaluate evidence to support the use of rivaroxaban in chronic coronary artery disease and peripheral arterial disease
  19. Discuss implications of findings of the COMPASS study for treatment of patients with chronic coronary artery disease and peripheral arterial disease
  20. Explain upadacitinib's place in the treatment of rheumatoid arthritis
  21. Identify appropriate dosing and monitoring for patients taking upadacitinib

Learning objectives for Pharmacy Technicians

  1.  List 3 uses of online technologies that will assist students during an institutional pharmacy rotation.
  2. Delineate methodologies that will enhance technician training during new employee orientation.  
  3. Identify the indication for PSCK9 inhibitors.
  4. Describe and implement appropriate storage recommendations for PCSK9 inhibitors.
  5. Recognize the route of administration for imipenem, cilastatin, and relebactam
  6. Recognize the available dosage formulations and the common doses of pitolisant
  7. Identify proper storage requirements for pitolisant
  8. Recognize the dose and dosage form that budesonide-formoterol is supplied as
  9. Recognize the brand/generic name, the dosages forms and the FDA indication of sacubitril/valsartan
  10. Recognize when to recommend pharmacist intervention in patients with self-reported penicillin allergies
  11. Illustrate the importance of properly documenting patient self-reported penicillin allergies
  12. Recognize the correlation between urinary symptoms and the diagnosis of a UTI
  13. Identify consequences of inappropriate antibiotic use
  14. Identify potential side effects of rivaroxaban in chronic coronary artery disease and peripheral arterial disease
  15. Describe appropriate storage requirements for upadacitinib
  16. Recognize available preparations of upadacitinib

Additional Information

AttachmentSize
NWPSHP Fall CE Day Flyer (2019).docx53.68 KB
Course summary
Available credit: 
  • 3.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 3.25 ACPE Technician
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 3.25 Attendance
Course opens: 
10/21/2019
Course expires: 
11/27/2019
Event starts: 
10/25/2019 - 8:00am
Event ends: 
10/25/2019 - 5:00pm
UPMC Hamot
Erie, PA
United States

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This knowledge-based activity provides 3.25 contact hours of continuing pharmacy education credit.

 

Universal Activity Number List: JA4008223-0000-19-006-L04-P and JA4008223-0000-19-006-L04-T

Available Credit

  • 3.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 3.25 ACPE Technician
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 3.25 Attendance

Accreditation Period

Course opens: 
10/21/2019
Course expires: 
11/27/2019
Please login or register to take this course.

Free to NWPSHP Members

$20 Fee for Non-Members

 

 

Pre-registration is required